Syros Pharmaceuticals Inc (SYRS)
0.2743
-0.09
(-23.78%)
USD |
NASDAQ |
Nov 14, 16:00
0.2793
0.00 (0.00%)
After-Hours: 16:39
Syros Pharmaceuticals Total Assets (Quarterly): 85.00M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 85.00M |
| June 30, 2024 | 106.72M |
| March 31, 2024 | 134.73M |
| December 31, 2023 | 168.17M |
| September 30, 2023 | 147.80M |
| June 30, 2023 | 180.98M |
| March 31, 2023 | 205.32M |
| December 31, 2022 | 244.49M |
| September 30, 2022 | 284.72M |
| June 30, 2022 | 126.23M |
| March 31, 2022 | 152.08M |
| December 31, 2021 | 182.94M |
| September 30, 2021 | 208.04M |
| June 30, 2021 | 233.73M |
| March 31, 2021 | 260.63M |
| December 31, 2020 | 213.25M |
| September 30, 2020 | 133.34M |
| June 30, 2020 | 147.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 161.40M |
| December 31, 2019 | 149.98M |
| September 30, 2019 | 143.83M |
| June 30, 2019 | 151.83M |
| March 31, 2019 | 88.43M |
| December 31, 2018 | 106.77M |
| September 30, 2018 | 120.63M |
| June 30, 2018 | 131.38M |
| March 31, 2018 | 128.10M |
| December 31, 2017 | 78.49M |
| September 30, 2017 | 88.68M |
| June 30, 2017 | 99.03M |
| March 31, 2017 | 78.02M |
| December 31, 2016 | 91.32M |
| September 30, 2016 | 100.41M |
| June 30, 2016 | 60.95M |
| March 31, 2016 | 70.82M |
| December 31, 2015 | 43.63M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
85.00M
Minimum
Sep 2024
284.72M
Maximum
Sep 2022
176.37M
Average
164.79M
Median
Total Assets (Quarterly) Benchmarks
| Baxter International Inc | 26.31B |
| AbbVie Inc | 143.42B |
| Elanco Animal Health Inc | 13.28B |
| Opus Genetics Inc | 44.83M |
| Entrada Therapeutics Inc | 554.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 96.12M |
| Shareholders Equity (Quarterly) | -11.12M |